SHANKAR SRINIVASAN: Open Payments
NPI 1093855728 · PARSIPPANY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,838 in 169 payments from 16 companies in 2025. Trend: 2023 $38,579 · 2024 $38,415 · 2025 $64,838
Honoraria: $37,088Speaker / faculty: $23,375Food & beverage: $2,844Travel & lodging: $1,518Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $23,813 |
| Supernus Pharmaceuticals, Inc. | 27 | $23,657 |
| Axsome Therapeutics, Inc. | 20 | $16,118 |
| Alkermes, Inc. | 17 | $358 |
| Vanda Pharmaceuticals Inc. | 13 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $171 |
| Neurocrine BioSciences, Inc. | 6 | $153 |
| Lundbeck LLC | 5 | $86 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
Products named: VRAYLAR, Qelbree, Auvelity, LYBALVI, FANAPT, TRINTELLIX, INGREZZA, ARISTADA.
Industry payments across NJ — which companies pay providers there.
